Related Experiment Video

Updated: May 31, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

Permanent implications of intrauterine growth restriction on cholesterol homeostasis

Gurjeev Sohi1, Andrew Revesz, Daniel B Hardy

  • 1The Department of Physiology & Pharmacology, The University of Western Ontario, London, Ontario, Canada.

Seminars in Reproductive Medicine
|June 29, 2011
PubMed

Insights

Adverse in utero conditions can program metabolic syndrome by affecting cholesterol levels. This review explores how fetal development, the placenta, and liver function are linked to cholesterol homeostasis and disease risk.

Area of Science:

  • Reproductive biology
  • Developmental biology
  • Metabolic disease research

Background:

  • Adverse in utero environments significantly impact long-term health, contributing to up to 50% of metabolic syndrome diseases.
  • The link between impaired fetal development and elevated cholesterol, a key risk factor for metabolic syndrome and cardiovascular disease, is not well understood.
  • Understanding these early-life influences is crucial for preventing chronic diseases later in life.

Purpose of the Study:

  • To review current research on fetal programming of cholesterol homeostasis.
  • To explore the role of the placenta in mediating cholesterol balance during pregnancy.
  • To uncover molecular mechanisms by which undernutrition or hypoxia in utero can impair liver cholesterol regulation.

Main Methods:

  • Review of clinical studies and animal models investigating fetal programming.
  • Analysis of research on placental function in cholesterol transport and metabolism.
  • Examination of molecular pathways in liver cholesterol homeostasis affected by developmental insults.

Main Results:

  • Fetal development and placental function are critical determinants of cholesterol homeostasis.
  • Undernutrition and hypoxia during gestation can disrupt molecular mechanisms regulating cholesterol in the liver.
  • These disruptions can lead to altered cholesterol levels with implications for fetal and postnatal health.

Conclusions:

  • The in utero environment plays a pivotal role in establishing lifelong cholesterol regulation.
  • The placenta is a key mediator, and its dysfunction can impact fetal cholesterol metabolism.
  • Impaired liver cholesterol homeostasis due to early-life stress has significant implications for metabolic and cardiovascular health.

More Related Videos

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...